8-K
Current Report
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001144204-11-041818
Restatement
- Item 4.02 Non-reliance on previously issued financial statements
From the SEC's structured data for this filing
Loading v229570_8k.htm…